Before you sell to, join or invest in Lumen Bioscience, Inc.
MentionFox check on Lumen Bioscience, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/lumen-bioscience-inc-form-d-25000001
Check Lumen Bioscience, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Lumen Bioscience, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Lumen Bioscience, Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-01.
Lumen Bioscience, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 1, 2025. Its industry group is Biotechnology. It names Brian Finrow (Executive Officer, Director, Promoter), James Roberts (Executive Officer, Director, Promoter), Erik Anderson (Director) (SEC Form D, April 1, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Lumen Bioscience, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Lumen Bioscience, Inc.
Free to see. No signup.
More on the people and the money behind Lumen Bioscience, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Lumen Bioscience, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Lumen Bioscience, Inc. raises, hires or launches. No email unless you switch it on.
Watch Lumen Bioscience, Inc. →Get the full cited report on Lumen Bioscience, Inc.
What the filing shows about Lumen Bioscience, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Lumen Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Lumen Bioscience, Inc.'s address as 1441 North 34TH Street, Suite 300, Seattle, WA 98103.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Lumen Bioscience, Inc. is a registered filer with the SEC (CIK 1703612) and has filed since 2023-09-15. 3 filings are on record, the latest on 2025-04-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Lumen Bioscience, Inc.'s Form D of 2025-04-01 names Brian Finrow, James Roberts, Erik Anderson and 7 more as its officers, directors or promoters.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Brian Finrow is named as Executive Officer and Director and Promoter on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
James Roberts is named as Executive Officer and Director and Promoter on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
Erik Anderson is named as Director on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
Robert Carlson is named as Director on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
Mark Litton is named as Director on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
Marcos Milla is named as Director on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
Craig Behnke is named as Executive Officer on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
Eric Orse is named as Executive Officer on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
John Morrow is named as Executive Officer on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
Ed Schlect is named as Director on the Form D that Lumen Bioscience, Inc. filed with the SEC on 1 April 2025, one of 10 people that filing names.
10 people named on the filing — 5 holding an executive role and 5 as directors only.
Named as of the 2025-04-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Lumen Bioscience, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Lumen Bioscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lumen Bioscience, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Lumen Bioscience, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Lumen Bioscience, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Lumen Bioscience, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Seattle
https://mentionfox.com/funding/lumen-bioscience-inc-form-d-25000001